Open access
3,335
Views
8
CrossRef citations to date
0
Altmetric
Reports
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
Chunyin Gua Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Xiaodan Caoa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Zongda Wanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Xue Hub State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Yanfeng Yaoc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Yiwu Zhoud Department of Forensic Medicine, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Peipei Liua Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Xiaowu Liua Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Ge Gaoc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Xiao Hub State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Yecheng Zhangb State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Zhen Chenb State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Li Gaoa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Yun Pengc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Fangfang Jiaa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Chao Shanb State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Li Yua Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Kunpeng Liub State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Nan Lia Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Weiwei Guob State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, People’s Republic of ChinaView further author information
, Guoping Jianga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Juan Minc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Jianjian Zhanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Lu Yanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Meng Shia Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Tianquan Houa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Yanan Lia Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Weichen Lianga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Guoqiao Lua Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Congyi Yanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Yuting Wanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Kaiwen Xiaa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Zheng Xiaoa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Jianhua Xuea Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Xueyi Huanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Xin Chena Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Haixia Mac Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Donglin Songc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaView further author information
, Zhongzong Pana Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Xueping Wanga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Haibing Guoa Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Hong Lianga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaView further author information
, Zhiming Yuanc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-3234-9616View further author information
Wuxiang Guanc Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Su-Jun Denga Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
show allView further author information
Article: 1930636
|
Received 03 Mar 2021, Accepted 12 May 2021, Published online: 07 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.